Home > M&A deals 2013 > Auven Therapeutics and MedImmune LLC invest in ADC Therapeutics SA
Growth Capital · Life Science · October 2013

Auven Therapeutics and MedImmune LLC invest in ADC Therapeutics SA

On October 15, 2013, Auven Therapeutics and MedImmune LLC invested in ADC Therapeutics SA, a life science company in Switzerland.

Deal at a glance

AnnouncedOctober 15, 2013 TypeGrowth Capital TargetADC Therapeutics SA Buyers Auven Therapeutics
MedImmune LLC SectorLife Science LocationSwitzerland ValueNot disclosed

Target company

ADC Therapeutics SA
Switzerland
Life Sciencesector
2003founded
Activestatus
View the company profile →

Buyers (2)

Auven Therapeutics Lead
Company · 4 deals on record
MedImmune LLC Co-investor
Company · 6 deals on record
  • 4th transaction for the lead buyer in life science
  • 2nd transaction in Switzerland
4deals, all time
4in this sector
2013latest

Members only

Contact details at the buyers and sellers
The full deal history of every party
Co-investors and the other advisors on this deal
Deal value and revenue or EBITDA multiples

Related deals

FGen AGSame sector and country · Mar 2022

Questions about this deal

Who acquired ADC Therapeutics SA?Auven Therapeutics and MedImmune LLC invested in ADC Therapeutics SA on October 15, 2013.

What type of deal was it?It was a growth capital in the life science sector in 2013.

See the full picture on AcquityDataContacts, full deal histories, co-investors and deal values. Free for a day with your Google account, no card needed.
Try it free
Data updated daily on AcquityData (Acquity Data).